Author(s): Aaron T. Gerds, Bart L. Scott, Peter Greenberg, et. al. Abstract: P 662 Session topic: 10. Myelodysplastic syndromes – Clinical Background: Treatment options are limited and prognosis is poor for patients (pts) with relapsed or refractory myelodysplastic syndromes (R/R MDS), those who relapse after or fail to achieve complete response with...
Pro zobrazení tohoto obsahu je třeba být přihlášen.